Aquestive Therapeutics (AQST) Interest & Investment Income: 2018-2025
Historic Interest & Investment Income for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to $306,000.
- Aquestive Therapeutics' Interest & Investment Income fell 68.74% to $306,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 34.21%. This contributed to the annual value of $3.4 million for FY2024, which is 78.94% down from last year.
- According to the latest figures from Q3 2025, Aquestive Therapeutics' Interest & Investment Income is $306,000, which was down 85.40% from $2.1 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Interest & Investment Income ranged from a high of $14.5 million in Q1 2023 and a low of -$52,000 during Q1 2021.
- In the last 3 years, Aquestive Therapeutics' Interest & Investment Income had a median value of $734,000 in 2024 and averaged $2.1 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 512.50% in 2021, then soared by 483,866.67% in 2023.
- Quarterly analysis of 5 years shows Aquestive Therapeutics' Interest & Investment Income stood at $135,000 in 2021, then tumbled by 51.85% to $65,000 in 2022, then spiked by 153.85% to $165,000 in 2023, then spiked by 344.85% to $734,000 in 2024, then plummeted by 68.74% to $306,000 in 2025.
- Its last three reported values are $306,000 in Q3 2025, $2.1 million for Q2 2025, and $713,000 during Q1 2025.